Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 356.5 | 54 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 581.0 | 46 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | M-CSF | 493.5 | 50 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 747.0 | 58 | |
N2759 | TNF-a | 100 | ng/mL | 3 | M-CSF | 740.5 | 38 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 483.0 | 47 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | M-CSF | 415.0 | 38 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | M-CSF | 579.5 | 44 | |
N2586 | TNF-a | 100 | ng/mL | 3 | M-CSF | 374.0 | 51 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 249.0 | 54 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | M-CSF | 290.5 | 54 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 456.5 | 50 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | M-CSF | 421.0 | 59 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 303.0 | 50 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | M-CSF | 279.5 | 50 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | M-CSF | 294.0 | 53 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | M-CSF | 344.0 | 55 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 323.0 | 58 | ||||
RA1869 | 3 | M-CSF | 301.0 | 55 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 441.0 | 45 | ||||
N2759 | 3 | M-CSF | 376.0 | 45 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 300.0 | 46 | ||||
RA1931 | 3 | M-CSF | 294.0 | 43 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | M-CSF | 156.5 | 40 | ||||
N2586 | 3 | M-CSF | 225.0 | 49 |